Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > FDA said more test were necessary to establish mcna efficacy
View:
Post by Xiawen13 on Mar 24, 2016 4:51pm

FDA said more test were necessary to establish mcna efficacy

But they havent ruled out commercialisation, have they?

remember that part of the (now infamous) john ford article?

What will Telesta be worth if the advisory committee suggests another Phase 3 trial, but allows Telesta to immediately commercialize the drug?

It's possible that Telesta could be allowed to immediately start selling MCNA, but concurrently conduct another phase 3 trial. Since everyone benefits by having this drug on the market as soon as possible, this could definitely be an option. Telesta would be able to generate significant revenue, while conducting the 2nd phase 3 trial.

At that point, Telesta should be valued in the $400 million range, given that it would be a full-fledged commercial company. What pulls the valuation down a bit is the cost of the 2nd phase 3 trial. But as the company begins generating serious revenue, the cost of the trial will be small in proportion to revenue, and will be less of an issue in the future.

What will Telesta be worth with FDA approval?

Comment by DamnYankees on Mar 24, 2016 5:07pm
The Ford article coincided with the pre Adcomm pump n dump. Good review but I think pampers saw the opportunity to use it as a reason to run the share price before the FDA mess and share price disaster. A lot has changed since then and the 5 cent share price and massive anon sell off should tell the tale.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities